Align Financial’s DexCom DXCM Stock Holding History

Align Financial’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$431	Buy	+5	New	+$416	﹤0.01%	519

Other funds holding DXCM

Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return

Fisher Funds Management Auckland, New Zealand $3.44B AUM 17.27% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Beacon Investment Advisory Services Morristown, New Jersey $2.66B AUM 29.77% 1-Year Est. Return

Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.31B AUM 25.55% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Align Financial's DXCM Position: Q3 2026 in Review

Align Financial opened a new position in DexCom (DXCM) in Q3 2026: 5 shares worth $431. The stake represents ﹤0.01% of the portfolio and ranks #519 among its holdings.

173 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

Align Financial held 5 shares of DexCom worth $431 as of Q3 2026.
DexCom was a new Align Financial position in Q3 2026.
DexCom made up ﹤0.01% of Align Financial's portfolio in Q3 2026, its #519 holding.
173 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Align Financial's 13F filing for Q3 2026, filed 16 Oct 2026.